Biomark Diagnostics Inc. (CSE:BUX)
Canada · Delayed Price · Currency is CAD 0.4500
-0.0300 (-6.25%)
Jan 20, 2026, 11:19 AM EST
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of CAD 54.27 million as of January 20, 2026. Its market cap has increased by 265.20% in one year.
Market Cap
54.27M
Enterprise Value
53.54M
Revenue
123.42K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.45
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 40.39M to 54.27M, an increase of 34.39%. That is a compound annual growth rate of 2.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 54.27M | 3.49% |
| Dec 30, 2025 | 52.44M | 254.54% |
| Dec 30, 2024 | 14.79M | -17.24% |
| Dec 29, 2023 | 17.87M | 24.67% |
| Dec 30, 2022 | 14.34M | -23.96% |
| Dec 30, 2021 | 18.85M | 116.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.85B |
| Green Thumb Industries | 2.58B |
| dentalcorp Holdings | 2.20B |
| Sienna Senior Living | 2.17B |
| Extendicare | 2.13B |
| Trulieve Cannabis | 2.02B |
| Cronos Group | 1.35B |
| Bright Minds Biosciences | 1.20B |